Arg389Gly polymorphism of the human β1-adrenergic receptor in patients with nonfatal acute myocardial infarction

American Heart Journal

Volumn 146, Issue 1, 2003, Pages 106-109

  Iwai, Chikao ^a   Akita, Hozuka ^a   Kanazawa, Kenji ^a   Shiga, Nobuyuki ^a   Terashima, Masahiro ^a   Matsuda, Yasuaki ^a   Takai, Eiji ^a   Miyamoto, Yoshitomo ^a   Shimizu, Masakatsu ^a   Kajiya, Teishi ^b   Hayashi, Takatoshi ^b   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Himeji Cardiovascular Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR;

ACUTE HEART INFARCTION; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION MAPPING; STATISTICAL ANALYSIS;

EID: 0037823079     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00110-8     Document Type: Article

References (14)

1. Tofler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol 1990;66:22-7.
2. Cohen MC, Muller JE. Onset of acute myocardial infarction-circadian variation and bn triggers. Cardiovasc Res 1992;26:831-8.
3. Frishman WH, Lazar EJ. Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade. Am J Cardiol 1990;66:66-70G.
4. Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation 1989;80:853-8.
5. Mason DA, Moore JD, Green SA, et al. A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 1999;274:12670-4.
6. Maqbool A, Hall AS, Ball SG, et al. Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay. Lancet 1999;353:897.
7. Tesson F, Charron P, Peuchmaurd M, et al. Characterization of a unique genetic variant in the β1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 1999;31:1025-32.
8. Muller JE, Kaufmann PG, Luepker RV, et al. Mechanisms of precipitating acute cardiac events: review and recommendations of an NHLBI workshop. Circulation 1997;96:3233-9.
9. The Norwegian Muhicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
10. Wikstrand J, Warnold I, Tuomilehto J, et al. Metoprolol versus thiazide diuretics in hypertension: morbidity results from the MAPHY Study. Hypertension 1991;17:579-88.
11. Zaman AG, Helft G, Worthley SG, et al. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000;149:251-6.
12. Terashima M, Akita H, Kanazawa K, et al. Stromelysin promoter 5A/6A-polymorphism is associated with acute myocardial infarction. Circulation 1999;99:2717-9.
13. Iwai C, Akita H, Shiga N, et al. A suppressive effect of the Gly389 allele of the β1-adrenergic receptor gene on ventricular tachycardia in dilated cardiomyopathy. Circ J 2002;66:723-8.
14. Julius S. The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension? Clin Exp Hypertens 1995;17:375-86.